The influence of a polymorphism in the gene encoding angiotensin converting enzyme (ACE) on treatment outcomes in late-onset Pompe patients receiving alglucosidase alfa-Reference-Cited by-同舟云学术

The influence of a polymorphism in the gene encoding angiotensin converting enzyme (ACE) on treatment outcomes in late-onset Pompe patients receiving alglucosidase alfa

Published:2016-09 Issue: Volume:8 Page:48-50
ISSN:2214-4269
Container-title:Molecular Genetics and Metabolism Reports
language:en
Short-container-title:Molecular Genetics and Metabolism Reports

Author:

Baek Rena C.,Palmer Rachel,Pomponio Robert J.,Lu Yuefeng,Ma Xiwen,McVie-Wylie Alison J.

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology

Reference17 articles.

1. Pompe's disease;van der Ploeg;Lancet,2008

2. Glycogen storage disease type II: acid α-glucosidase (acid maltase deficiency);Hirschhorn,2001

3. Consensus treatment recommendations for late-onset Pompe disease;Cupler;Muscle Nerve,2012

4. Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review;Toscano;J. Neurol.,2013

5. A randomized study of alglucosidase alfa in late-onset Pompe's disease;van der Ploeg;New. Engl. J. Med.,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymorphism in exercise genes and respiratory function in late-onset Pompe disease;Journal of Applied Physiology;2021-12-01

2. Gene therapy with secreted acid alpha-glucosidase rescues Pompe disease in a novel mouse model with early-onset spinal cord and respiratory defects;EBioMedicine;2020-11

3. Molecular genetics of Pompe disease: a comprehensive overview;Annals of Translational Medicine;2019-07

4. A genetic modifier of symptom onset in Pompe disease;EBioMedicine;2019-05

5. Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group;Advances in Therapy;2019-03-16